|
Volumn 2, Issue 11, 2005, Pages 493-493
|
Top-down versus step-up approaches to chronic inflammatory bowel disease: Presumed innocent or presumed guilty
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOSALICYLIC ACID DERIVATIVE;
CORTICOSTEROID;
IMMUNOSUPPRESSIVE AGENT;
TUMOR NECROSIS FACTOR ANTIBODY;
BIOLOGICAL THERAPY;
CROHN DISEASE;
DISEASE SEVERITY;
EDITORIAL;
ENTERITIS;
EVIDENCE BASED MEDICINE;
HUMAN;
INTERMETHOD COMPARISON;
INTESTINE FISTULA;
INTESTINE MUCOSA;
INTESTINE STENOSIS;
PATIENT CARE;
PRIORITY JOURNAL;
SAMPLE SIZE;
ULCERATIVE COLITIS;
ADRENAL CORTEX HORMONES;
BIOLOGICAL THERAPY;
CROHN DISEASE;
EVIDENCE-BASED MEDICINE;
HUMANS;
PATIENT SELECTION;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 31344455134
PISSN: 17434378
EISSN: 17434386
Source Type: Journal
DOI: 10.1038/ncpgasthep0318 Document Type: Editorial |
Times cited : (26)
|
References (0)
|